SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

Biotie Therapies Corp.

(Name of Issuer)

 

 

American Depository Shares

(Title of Class of Securities)

09074D103

(CUSIP Number)

April 11, 2016

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

x Rule 13d-1(c)

 

¨ Rule 13d-1(d)

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


  CUSIP No. 09074D103

 

  1   

NAMES OF REPORTING PERSONS

 

Vivo Capital VIII, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

  (a)   ¨

  (b)   ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     5    

SOLE VOTING POWER

 

    0

     6   

SHARED VOTING POWER

 

    0

     7   

SOLE DISPOSITIVE POWER

 

    0

     8   

SHARED DISPOSITIVE POWER

 

    0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    0

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 

     ¨

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    0%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

    OO


I TEM  1. (a) N AME OF I SSUER :

Biotie Therapies Corp.

 

  (b) A DDRESS OF I SSUER S P RINCIPAL E XECUTIVE O FFICES :

Joukahaisenkatu 6, FI-20520, Turku, Finland

 

I TEM  2. (a) N AME OF P ERSON F ILING :

Vivo Capital VIII, LLC

 

  (b) A DDRESS OF P RINCIPAL B USINESS O FFICE OR , IF N ONE , R ESIDENCE :

575 High Street, Suite 201, Palo Alto, CA 94301

 

  (c) C ITIZENSHIP :

Vivo Capital VIII, LLC, is a Delaware limited liability company.

 

  (d) T ITLE OF C LASS OF S ECURITIES :

American Depositary Shares

 

  (e) CUSIP N UMBER :

09074D103

 

I TEM  3. I F T HIS S TATEMENT IS F ILED P URSUANT TO §§ 240.13d-1(b), OR 240.13d-2(b) OR (c), C HECK W HETHER THE P ERSON F ILING IS A :

 

  (a) ¨ Broker or dealer registered under Section 15 of the Act.

 

  (b) ¨ Bank as defined in Section 3(a)(6) of the Act.

 

  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act.

 

  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940.

 

  (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

 

  (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

 

  (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(l)(ii)(G);

 

  (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

 

  (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

 

  (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

 

  (k) ¨ Group, in accordance with § 240.13d-1(b)(l)(ii)(K).

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1(ii)(j), please specify the type of institution:                         

Not Applicable.


I TEM  4. O WNERSHIP .

 

  (a) A MOUNT BENEFICIALLY OWNED :

None.

 

  (b) P ERCENT OF CLASS :

0%

 

  (c) N UMBER OF SHARES AS TO WHICH SUCH PERSON HAS :

 

  (i) Sole power to vote or to direct the vote: 0

 

  (ii) Shared power to vote or to direct the vote: 0

 

  (iii) Sole power to dispose or to direct the disposition of: 0

 

  (iv) Shared power to dispose of or to direct the disposition of: 0

 

I TEM  5. O WNERSHIP OF F IVE P ERCENT OR L ESS OF A C LASS .

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. x

 

I TEM  6. O WNERSHIP OF M ORE THAN F IVE P ERCENT ON B EHALF OF A NOTHER P ERSON .

Not Applicable.

 

I TEM  7. I DENTIFICATION AND C LASSIFICATION OF THE S UBSIDIARY W HICH A CQUIRED THE S ECURITY B EING R EPORTED ON BY THE P ARENT H OLDING C OMPANY OR C ONTROL P ERSON .

Not Applicable.

 

I TEM  8. I DENTIFICATION AND C LASSIFICATION OF M EMBERS OF THE G ROUP .

Not applicable.

 

I TEM  9. N OTICE OF D ISSOLUTION OF G ROUP .

Not applicable.

 

I TEM  10. C ERTIFICATIONS .

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Vivo Capital VIII, LLC
April 14, 2016
(Date)
/s/ Albert Cha
(Signature)
Managing Member
(Title)
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse BIOTIE THERAPIES CORP.
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse BIOTIE THERAPIES CORP.